Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

HIV-1 inhibitor-47

Catalog No. T60342 Copy Product Info
Purity: 99.95%
🥰Excellent
HIV-1 inhibitor-47 is a potent HIV-1 reverse transcriptase (RT) inhibitor. It suppresses viral replication by blocking RNA-to-DNA conversion, used for developing new therapies against drug-resistant HIV strains.

HIV-1 inhibitor-47

Copy Product Info
🥰Excellent
Catalog No. T60342

HIV-1 inhibitor-47 is a potent HIV-1 reverse transcriptase (RT) inhibitor. It suppresses viral replication by blocking RNA-to-DNA conversion, used for developing new therapies against drug-resistant HIV strains.

HIV-1 inhibitor-47
Cas No. 137448-39-6
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$30-In Stock
5 mg$68-In Stock
10 mg$112-In Stock
25 mg$186-In Stock
50 mg$277-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.95%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
HIV-1 inhibitor-47 is a potent HIV-1 reverse transcriptase (RT) inhibitor. It suppresses viral replication by blocking RNA-to-DNA conversion, used for developing new therapies against drug-resistant HIV strains.
In vitro
In virology research, APOBEC3G acts as a critical host factor that induces hypermutation in the HIV-1 genome, thereby arresting replication. HIV-1 inhibitor-47 specifically disrupts the Vif-APOBEC3G interaction, preventing Vif from recruiting the E3 ubiquitin ligase complex to degrade A3G. By stabilizing A3G levels, the compound significantly enhances the antiviral state of the host cell. Furthermore, its chemical scaffold, characteristic of many psychotropic agents, suggests potential multi-target activity in modulating neurotransmitter pathways associated with mood disorders [1][2].
Chemical Properties
Molecular Weight242.28
FormulaC12H14N6
Cas No.137448-39-6
SmilesN=1C=CN=C(C1)N2CCN(C3=NC=CC=N3)CC2
Storage & Solubility Information
StorageKeep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 13 mg/mL (53.66 mM), Sonication is recommmended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM4.1275 mL20.6373 mL41.2746 mL206.3728 mL
5 mM0.8255 mL4.1275 mL8.2549 mL41.2746 mL
10 mM0.4127 mL2.0637 mL4.1275 mL20.6373 mL
20 mM0.2064 mL1.0319 mL2.0637 mL10.3186 mL
50 mM0.0825 mL0.4127 mL0.8255 mL4.1275 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy HIV-1 inhibitor-47 | purchase HIV-1 inhibitor-47 | HIV-1 inhibitor-47 cost | order HIV-1 inhibitor-47 | HIV-1 inhibitor-47 chemical structure | HIV-1 inhibitor-47 in vitro | HIV-1 inhibitor-47 formula | HIV-1 inhibitor-47 molecular weight